The functional role of CARM1-mediated GATAD2A methylation in breast cancer cell growth prompted us to examine whether targeting CARM1-mediated GATAD2A methylation using CARM1 inhibitors, EZM2302 and TP-064, could inhibit breast cancer cell growth. The gene discussed is GATAD2A; the disease is breast carcinoma.